Effects of celecoxib on major prostaglandins in asthma.

Summary: Asthma is often a battle of balance within the lungs. Some natural chemicals tighten airways, while others relax them. In this study, researchers tested Celecoxib—a common pain reliever known as a COX-2 inhibitor—to see how it affects this chemical balance in asthmatics.

The findings raised a red flag. While Celecoxib successfully blocked the production of "good" relaxing chemicals (PGE2), it failed to stop the "bad" tightening chemicals (PGD2), which appear to be made by a different enzyme (COX-1) in asthma patients. This means taking this drug could accidentally strip away the lungs' natural defenses while leaving the harmful inflammation unchecked. Although a short 3-day test didn't show immediate breathing problems, the study suggests that long-term use might disrupt airway health.